Neuropathologies that affect our population include ischemic stroke and neurodegenerative diseases of immune origin, including multiple sclerosis. The endocannabinoid system in the brain, including agonists anandamide (arachidonyl ethanolamide) and 2-arachidonoylglycerol, and the CB1 and CB 2 cannabinoid receptors, has been implicated in the pathophysiology of these disease states, and can be a target for therapeutic interventions. This review concentrates on cellular signal transduction pathways believed to be involved in the cellular damage. © Springer Science+Media, Inc. 2006.
CITATION STYLE
Howlett, A. C., Mukhopadhyay, S., & Norford, D. C. (2006). Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. In Journal of Neuroimmune Pharmacology (Vol. 1, pp. 305–316). https://doi.org/10.1007/s11481-006-9022-6
Mendeley helps you to discover research relevant for your work.